secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001683168-24-008640
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals holds virtual analyst and investor day; presentation content not detailed in filing excerpt
--------------------------------------------------------------------------------

- Virtual analyst and investor day held on December 11, 2024.
- Presentation furnished as Exhibit 99.1 was reviewed at the meeting.
- No financial results, guidance, or material updates disclosed in the provided exhibit excerpt.
- Filing under Item 7.01 Regulation FD; presentation not filed for Exchange Act purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824008640/0001683168-24-008640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824008640/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer